B3GAT1 and breast carcinoma: Nonetheless, our finding was in contrast to the results of other studies which found better survivals in patients having a higher level of tumoral CD57 NK cells in head and neck SCC, lung SCC, breast carcinoma, esophageal carcinoma, metastatic carcinoma, gastric carcinoma, and colorectal cancer18,28,32,66,96–99.